Healthcare >> CEO Interviews >> September 13, 2002

Andrew Whiteley – Informax Inc (inmx)

Andrew Whiteley has served as Chief Executive Officer, President and Chairman of the Board of Directors of InforMax since April of 2002. Mr. Whiteley has served as a director at the company since August 2000. Mr. Whiteley was previously the Vice President of Bioinformatics for Amersham Pharmacia Biotech, Inc., a provider of integrated drug discovery solutions, since January 2000. From October 1997 to December 1999, Mr. Whiteley served as Vice President of Amersham Pharmacia Biotech's sequencing business. For a portion of the period above, Mr. Whiteley also served as site director for Amersham International PLC's Cleveland facility. From April 1995 to March 1997, Mr. Whiteley was the head of Amersham International's group marketing. Mr. Whiteley received Bachelor's degrees in Chemistry and Biochemistry from Nottingham University in the UK in 1980. Profile
TWST: Would you begin with a brief historical sketch of InforMax and

follow that with an overview of things as they are now at the company?

Mr. Whiteley: InforMax was one of the earliest